Table 3.
Chi Square Analysis
| Time Between Surgery and Initiation of Chemotherapy | ||||||
|---|---|---|---|---|---|---|
| Less Than 30 Days | Between 30–60 Days | Between 61–90 Days | More Than 90 Days | p | ||
| Age | ≤60 | 11 | 21 | 10 | 9 | 0.53 |
| >60 | 15 | 17 | 6 | 11 | ||
| Marital status | Widow, single, divorced | 6 | 14 | 1 | 9 | 0.07 |
| Married, free union | 15 | 14 | 10 | 10 | ||
| Number of comorbidities | 0–1 | 19 | 28 | 8 | 14 | 0.05 |
| ≥2 | 7 | 4 | 8 | 6 | ||
| Type of surgery | ALND or mastectomy | 12 | 13 | 8 | 7 | 0.61 |
| No ALND or mastectomy | 14 | 25 | 8 | 13 | ||
| Stage | I–II | 20 | 30 | 10 | 12 | 0.34 |
| III | 6 | 8 | 6 | 8 | ||
| Biological subtype | TN | 6 | 6 | 1 | 3 | 0.79 |
| Her2 like | 4 | 9 | 4 | |||
| HR+, HER2- | 16 | 23 | 13 | 10 | ||